rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Rajeev Saggar

Chief Medical Officer

Company insider

Files Form 4 as: Chief Medical Officer, Liquidia.

Every Form 4 they filed

In numbers

Trades disclosed
85
Buys
0
Sells
25
Bought
$0
Sold
$21.9M
Companies
1
Companies where not an officer
0
First trade
18 Jul 2022
Last trade
12 Oct 2026
Last filed
13 Oct 2026

Companies traded

Where they are an officer
LQDA LiquidiaOfficer · Biotechnology · last 12 Oct 20260 buys · 25 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
12 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$263K9,218 at $28.48filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,530filing
9 Oct 2026filed 13 Oct 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—4,486filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,530 at $0.00filing
9 Oct 2026filed 13 Oct 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—4,486 at $0.00filing
19 Aug 2026filed 19 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$187K50,000 at $3.73filing
19 Aug 2026filed 19 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$3.7M50,000 at $74.06filing
19 Aug 2026filed 19 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—50,000 at $0.00filing
19 Aug 2026filed 19 Aug 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—50,000 at $0.00filing
19 Aug 2026filed 19 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M$187K50,000 at $3.73filing
19 Aug 2026filed 19 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$3.7M50,000 at $74.06filing
17 Aug 2026filed 19 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$2.3M29,534 at $76.84filing
17 Aug 2026filed 19 Aug 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$2.3M29,534 at $76.84filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$50K703 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$660K9,223 at $71.52filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$50K703 at $71.39filing
13 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Sold$660K9,223 at $71.52filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—3,531filing
10 Jul 2026filed 14 Jul 2026LQDA LiquidiaBiotechnologySEC FORM 4 Code M—4,487filing
10 Jul 2026filed 14 Jul 2026LQDA Liquidiaoption or derivative · BiotechnologySEC FORM 4 Code M—3,531 at $0.00filing

Sectors

Health Care25

Buys in green, sells in red, by the company’s sector.

Related people

Roger JeffsChief Executive Officer · Chief Executive Officer at Liquidia, filing Form 4 there in the last year
Michael KasetaCFO and COO · CFO and COO at Liquidia, filing Form 4 there in the last year
Jason AdairChief Business Officer · Chief Business Officer at Liquidia, filing Form 4 there in the last year
Scott MoomawChief Commercial Officer · Chief Commercial Officer at Liquidia, filing Form 4 there in the last year
Russell SchundlerGeneral Counsel · General Counsel at Liquidia, filing Form 4 there in the last year
Dana BoyleChief Accounting Officer · Also traded LQDA in the last 90 days
Sanjeev KhindriChief Development Officer · Also traded LQDA in the last 90 days
Sarah KreppChief Human Resource Officer · Also traded LQDA in the last 90 days